ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Phase II Trial of CI-958 in Recurrent Platinum-Sensitive Ovarian Carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1006/gyno.2001.6182
◽
2001
◽
Vol 81
(3)
◽
pp. 433-435
◽
Cited By ~ 4
Author(s):
Mark A. Hoffman
◽
John A. Blessing
◽
Evelyn R. Nuñez
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Platinum Sensitive
Download Full-text
Related Documents
Cited By
References
A phase II trial of dolastatin-10 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study
Gynecologic Oncology
◽
10.1016/s0090-8258(03)00007-6
◽
2003
◽
Vol 89
(1)
◽
pp. 95-98
◽
Cited By ~ 42
Author(s):
Mark A Hoffman
◽
John A Blessing
◽
Samuel S Lentz
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Platinum Sensitive
◽
Dolastatin 10
Download Full-text
Phase II Trial of Pyrazoloacridine in Recurrent Platinum-Sensitive Ovarian Cancer: A Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1006/gyno.2001.6441
◽
2002
◽
Vol 84
(1)
◽
pp. 32-35
◽
Cited By ~ 9
Author(s):
Steven C. Plaxe
◽
John A. Blessing
◽
Michael A. Bookman
◽
William T. Creasman
Keyword(s):
Ovarian Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Platinum Sensitive
Download Full-text
Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma—a Gynecologic Oncology Group Study
Gynecologic Oncology
◽
10.1016/s0090-8258(03)00068-4
◽
2003
◽
Vol 89
(1)
◽
pp. 148-154
◽
Cited By ~ 51
Author(s):
Jeffrey D Bloss
◽
Mark F Brady
◽
Shu Yuan Liao
◽
Thomas Rocereto
◽
Edward E Partridge
◽
...
Keyword(s):
Ovarian Carcinoma
◽
Papillary Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Serous Ovarian Carcinoma
◽
Serous Papillary Carcinoma
Download Full-text
A Phase II Trial of Gallium Nitrate (NSC #15200) in Previously Treated Ovarian Carcinoma A Gynecologic Oncology Group Study
American Journal of Clinical Oncology
◽
10.1097/00000421-199108000-00015
◽
1991
◽
Vol 14
(4)
◽
pp. 349-351
◽
Cited By ~ 8
Author(s):
John H. Malfetano
◽
John A. Blessing
◽
Mark D. Adelson
Keyword(s):
Ovarian Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gallium Nitrate
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Previously Treated
Download Full-text
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study
Yearbook of Oncology
◽
10.1016/s1040-1741(08)70331-2
◽
2007
◽
Vol 2007
◽
pp. 82-83
Author(s):
J.T. Thigpen
Keyword(s):
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Weekly Paclitaxel
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Faculty Opinions recommendation of Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717969752.793471344
◽
2013
◽
Author(s):
David Kushner
◽
Ryan Spencer
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)
American Journal of Obstetrics and Gynecology
◽
10.1016/0002-9378(89)90507-3
◽
1989
◽
Vol 161
(2)
◽
pp. 309-312
◽
Cited By ~ 110
Author(s):
Gregory P. Sutton
◽
John A. Blessing
◽
Neil Rosenshein
◽
Guy Photopulos
◽
Philip J. DiSaia
Keyword(s):
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: A Gynecologic Oncology Group study
Gynecologic Oncology
◽
10.1016/j.ygyno.2015.01.055
◽
2015
◽
Vol 137
◽
pp. 24
◽
Cited By ~ 2
Author(s):
K.N. Moore
◽
M. Sill
◽
M.E. Tenney
◽
C.J. Darus
◽
D. Griffin
◽
...
Keyword(s):
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Oncology Group Study
◽
Recurrent Carcinoma
◽
Amg 386
◽
Angiopoietin 1
Download Full-text
A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: A Gynecologic Oncology Group study
Gynecologic Oncology
◽
10.1016/0090-8258(92)90055-n
◽
1992
◽
Vol 44
(3)
◽
pp. 268-270
◽
Cited By ~ 11
Author(s):
Allan J. Jacobs
◽
John A. Blessing
◽
Alan Munoz
Keyword(s):
Cervical Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Didemnin B
◽
Oncology Group
◽
Oncology Group Study
Download Full-text
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study
Yearbook of Oncology
◽
10.1016/s1040-1741(10)79511-7
◽
2010
◽
Vol 2010
◽
pp. 73-74
Author(s):
J.T. Thigpen
Keyword(s):
Endometrial Carcinoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Gynecologic Oncology
◽
Gynecologic Oncology Group
◽
Oncology Group
◽
Her2 Positive
◽
Oncology Group Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close